My 1Health Rewards: Earn benefits you can keep or give away. Learn more →

Cancer Treatment at King Faisal Specialist Hospital in Saudi Arabia

Treating 25% of all cancer cases in Saudi Arabia, 90% recovery in leukaemia and 92% 5-year survival rate for childhood ALL

Oncology/Cancer Treatment at King Faisal Specialist Hospital and Research Centre
Gulf's largest Cancer Centre, WHO-accredited for cancer prevention, 200+ patients treated with CAR-T cell therapy

Why Choose KFSH&RC for Cancer Treatment in Saudi Arabia

Gulf region's largest cancer facility and 1st centre in the Middle East to manufacture CAR-T cell therapy locally
Ranked 1st in the Middle East and among the World's Best Hospitals in 2026 (Newsweek). You receive a dedicated patient coordinator, airport-to-hospital transfer, written treatment plan before first appointment
  • CAR-T therapy manufactured locally, cost reduced by 80%.
  • 500+ new paediatric cancer cases accepted annually.
  • WHO-accredited Collaborating Centre for Cancer Prevention and Control.
  • Remote follow-up via AlTakhassusi App after returning home.
  • International patients from 17 countries treated.
  • Reports reviewed remotely before you commit to travel.

Cancer Treatment Diagnostic and Treatment Technology at KFSH&RC

Tech used affects how precisely tumours are targeted, how much healthy tissue is protected, and how quickly you recover between sessions
  • CyberKnife Robotic Radiosurgery
  • TomoTherapy Radiation System
  • Intensity-Modulated Radiation Therapy (IMRT)
  • CAR-T Cell Manufacturing Platform
  • Intra-Operative Radiation Therapy (IORT)
  • Stereotactic Radiosurgery (SRS)
  • High-Intensity Focused Ultrasound (HIFU)
  • MRI-Guided Radiation Simulation

Cancer Treatment at KFSH&RC for International Patients

Each cancer case is reviewed by a tumour board that considers your diagnosis, stage, and personal health before treatment plan
CAR-T Cell Therapy The only Arab world centre manufacturing CAR-T locally; 200+ patients treated since 2020 for treatment-resistant blood cancers including leukaemia, lymphoma, and multiple myeloma. Inquire
Paediatric Cancer 400+ new paediatric cancer cases annually with a 92% 5-year survival rate for childhood ALL; COG, EBMT, NMDP, and CIBMTR accredited. Inquire
Chemotherapy Personalised chemotherapy for solid tumours and blood cancers, delivered through ambulatory and inpatient infusion with disease-specific tumour board oversight. Inquire
Radiation Oncology CyberKnife, TomoTherapy, IMRT, and IORT available; first VERSA LINAC in the Middle East, treating brain, breast, prostate, lung, and head and neck cancers. Inquire
Robotic Cancer Surgery Robotic tumour removal across colorectal, gastric, oesophageal, breast, and gynaecological cancers, with HIPEC available for selected peritoneal cancers. Inquire
Targeted Therapy and Immunotherapy Molecularly guided drugs based on genomic profiling of the specific tumour, delivered as infusions or oral tablets for breast, lung, colorectal, and haematological cancers. Inquire
HIFU for Prostate Cancer First hospital in Saudi Arabia to offer HIFU with MRI-guided targeting and robotic probe positioning for localised low-to-intermediate risk prostate cancer. Inquire

Care Journey for International Patients

Your cancer treatment journey made simple and stress-free in 5 easy steps
  • 1
    Online inquiry & medical files upload Share your medical reports for review. It takes less than a minute.
  • 2
    Doctor review & treatment plan Within 24hrs you will receive treatment options & a preliminary plan before travel.
  • 3
    Travel coordination We arrange your visa, flights, and accommodation.
  • 4
    Treatment phase Full care under a dedicated case manager.
  • 5
    Start your treatment Begin treatment with full support from our care team.

Frequently Asked Questions

Have a question? Our support team is here to guide you through each step of your treatment journey with personal care and attention.
Can KFSH&RC review my cancer scans and reports before I travel?
Yes. A specialist tumour board reviews your reports, imaging, and pathology remotely before you commit to travel. You receive a written clinical assessment confirming your suitability before any travel arrangements are made. Submit your reports via WhatsApp at +1 718 550 0880 or email [email protected].
Does KFSH&RC treat children with cancer?
Yes. The King Fahad National Centre for Children's Cancer accepts 400+ new paediatric cases annually, comparable in volume to St. Jude Children's Research Hospital. The programme carries COG, EBMT, NMDP, and CIBMTR accreditation, with a 92% 5-year survival rate for childhood ALL and 97% for renal tumours. Families receive accommodation guidance, airport coordination, and Arabic and English language support.
How do I contact the cancer treatment international patient support team at KFSH&RC?
Cancer consultations, second opinions, and treatment coordination at KFSH&RC in Saudi Arabia are managed through the International Patient Care Centre. - WhatsApp: +1 718 550 0880 - Telephone: +1 718 550 0880 - Email: [email protected] The team is available 24/7 and can arrange online consultations, remote tumour board reviews, in-person appointments, and full oncology coordination with your assigned specialist.
How long will I need to stay in Saudi Arabia for cancer treatment?
Stay duration depends on the treatment required: - Chemotherapy: planned outpatient visits over weeks to months - Bone marrow or stem cell transplant: 4 to 6 weeks inpatient - CAR-T cell therapy: 2 to 4 weeks post-infusion monitoring - Radiation therapy: 4 to 7 weeks of daily sessions - Robotic cancer surgery: 1 to 3 weeks Your coordinator provides a written itinerary before you book flights or apply for a visa.
Is CAR-T cell therapy available for international patients at KFSH&RC?
Yes. KFSH&RC has treated 200+ patients with CAR-T since 2020 and in 2024 became the only centre in the Arab world to manufacture CAR-T cells locally, cutting preparation time by half. The therapy is used for treatment-resistant blood cancers including acute lymphoblastic leukaemia, diffuse large B-cell lymphoma, and multiple myeloma. Your coordinator confirms eligibility based on your diagnosis and treatment history before you proceed.
What makes KFSH&RC different from other cancer centres in the Gulf?
Three distinctions set it apart from every other Gulf oncology centre: - Only Arab world centre manufacturing CAR-T cells locally, cutting costs by 80% and preparation time by half - Gulf's largest cancer facility; WHO-accredited Collaborating Centre for Cancer Prevention and Control - 5,100+ bone marrow transplants with simultaneous EBMT, CIBMTR, NMDP, and COG accreditation, rare even globally For GCC patients, KFSH&RC is the only option for several treatments that do not exist locally.
Talk to a Patient Support Specialist